Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CYCSP45 (Cytochrome c pseudogene 45), also known as HCP45, is one of at least 49 pseudogenes in the human genome related to the cytochrome c gene (CYCS)[4][5]. These pseudogenes, including CYCSP45, are nonfunctional genomic DNA sequences that resemble the functional CYCS gene but have accumulated mutations that prevent them from encoding active cytochrome c protein[4][5]. Such pseudogenes typically result from retrotransposition events, and most are not expressed, do not produce protein, and have no known active biological or disease-related role in humans[4][5]. There is no evidence or literature indicating that CYCSP45 is a therapeutic target, a disease-linked gene, a receptor, enzyme, or otherwise involved in drug response or safety considerations. The alternative name HCP45 reflects its historical annotation in some genomic databases or sequence alignments[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c pseudogene 45 (CYCSP45).